Pamela S. VanderVere-Carozza

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Discovery and development of novel DNA-PK inhibitors by targeting the unique Ku–DNA interaction”.

Discovery and development of novel DNA-PK inhibitors by targeting the unique Ku–DNA interaction

Nucleic Acids Research(2020)10.1093/nar/gkaa934

N/A

0DataRank · unranked

48 citations

Pamela S. VanderVere-Carozza, Katherine S. Pawelczak, Pamela L Mendoza-Munoz, Tyler L. Vernon, Leslyn A. Hanakahi +8 more

Discovery and Development of Novel DNA-PK Inhibitors by Targeting the unique Ku-DNA Interaction

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.08.24.261875

N/A

0DataRank · unranked

4 citations

Pamela S. VanderVere-Carozza, Katherine S. Pawelczak, Tyler L. Vernon, Leslyn A. Hanakahi, Matthew Summerlin +7 more

Chemical exhaustion of RPA in cancer treatment

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.11.30.404640

N/A

0DataRank · unranked

4 citations

Katherine S. Pawelczak, Navnath S. Gavande, Shadia I. Jalal, Karen E. Pollok, Elmira Ekinci +4 more

OB-Folds and Genome Maintenance: Targeting Protein–DNA Interactions for Cancer Therapy

Cancers(2021)10.3390/cancers13133346

N/A

0DataRank · unranked

13 citations

Sofia Vaides, Pamela S. VanderVere-Carozza, Katherine S. Pawelczak, Jason A. Stewart, John J. Turchi +1 more

Recent Advances in the Development of Non-PIKKs Targeting Small Molecule Inhibitors of DNA Double-Strand Break Repair

Frontiers in Oncology(2022)10.3389/fonc.2022.850883

N/A

0DataRank · unranked

24 citations

Amirreza Samarbakhsh, Athira Pillai, Pamela S. VanderVere-Carozza, Hariprasad Aruri, Deepti S. Pandey +4 more

In Vivo Targeting Replication Protein A for Cancer Therapy

Frontiers in Oncology(2022)10.3389/fonc.2022.826655

N/A

0DataRank · unranked

23 citations

Navnath S. Gavande, Shadia I. Jalal, Karen E. Pollok, Elmira Ekinci, Joshua Heyza +5 more

Ku–DNA binding inhibitors modulate the DNA damage response in response to DNA double-strand breaks

NAR Cancer(2023)10.1093/narcan/zcad003

N/A

0DataRank · unranked

8 citations

Navnath S. Gavande, Pamela S. VanderVere-Carozza, Katherine S. Pawelczak, Joseph R. Dynlacht, Joy Garrett +2 more

Biochemical impact of p300-mediated acetylation of replication protein A: Implications for DNA metabolic pathway choice

Journal of Biological Chemistry(2025)10.1016/j.jbc.2025.110250

N/A

0DataRank · unranked

1 citations

Sneha Surendran, Tripthi Battapadi, Pamela S. VanderVere-Carozza, Olivia Kay Howald, Athena Kantartzis-Petrides +6 more

Chemical inhibition of RPA gap protection sensitizes BRCA1-deficient cancers to PARP inhibition

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.04.09.647957

N/A

0DataRank · unranked

0 citations

Matthew R. Jordan, Joy Garrett, Karen E. Pollok, Hilary D. Hinshaw, Xierzhatijiang Sulaiman +5 more

Design, synthesis, and structure–activity relationship studies of 4-substituted phenylpyrazolidinone derivatives as potent Ku70/80 targeted DNA-PK inhibitors

RSC Medicinal Chemistry(2025)10.1039/d5md00263j

N/A

0DataRank · unranked

0 citations

Pamela S. VanderVere-Carozza, Tyler L. Vernon, Pamela L. Mendoza-Munoz, Jitender Dev Gaddameedi, Karim Ben Ali Gacem +5 more